Related Experiment Videos
Development of TRPM8 Antagonists to Treat Chronic Pain and Migraine
1Pacific University School of Physical Therapy, Hillsboro, OR 97123, USA. andy.weyer@pacificu.edu.
Pharmaceuticals (Basel, Switzerland)
|March 31, 2017
Abstract:
A review. Development of pharmaceutical antagonists of transient receptor potential melastatin 8 (TRPM8) have been pursued for the treatment of chronic pain and migraine. This review focuses on the current state of this progress.